Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Alterations of the Dpc4 tumor suppressor gene in sporadic colon carcinoma : identification of noval somatic mutation in tumor from Croatian patient (CROSBI ID 483880)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Popović Hadžija, Marijana ; Kapitanović, Sanja ; Radošević, Senka ; Spaventi, Radan ; Hadžija, Mirko ; Pavelić, Krešimir Alterations of the Dpc4 tumor suppressor gene in sporadic colon carcinoma : identification of noval somatic mutation in tumor from Croatian patient // Eur J Cancer / Moranr, R. (ur.). Sankt Gallen: Pergamon, 2002. str. S50-x

Podaci o odgovornosti

Popović Hadžija, Marijana ; Kapitanović, Sanja ; Radošević, Senka ; Spaventi, Radan ; Hadžija, Mirko ; Pavelić, Krešimir

engleski

Alterations of the Dpc4 tumor suppressor gene in sporadic colon carcinoma : identification of noval somatic mutation in tumor from Croatian patient

Dpc4 is functionally inactivated in about 10-20% of colorectal mutations. The role of DPC4 alterations in development and/or progression of colorectal tumors, we analyzed on 60 samples of Croatian patients. We investigated allelic losses and mutations in exons 8, 10 and 11. In this work we used polymerase chain reaction (PCR) as basic methods and variable nucleotide tandem re- peat (VNTR) analysis for three flanking markers (D18S474, D18S363, D18S46). LOH analysis was prepared on the acrylamide-Bis-acrylarnide gels with Spreadex polymer NAB, a novel gel matrix for DNA electrophoresis. In restriction fragment polymorphism (RFLP) analysis we used Mnll, Mael, and BspHI restriction site. Single strand conformation polymorphism (SSCP) was done onto GMA gels in denaturing conditions. Among 60 analyzed cases of colorectal cancers even 58% (97% ) were informative. LOH at any of three flanking markers was detected in 37 (64%) of informative tumor DNA's. Nine- teen cases of LOH found by D18S474 marker, 11 cases found by D18S363 marker, and 7 cases found by D18S46 marker, respectively. In RFLP analysis neither exarnined samples of colon carcinoma were positive for mutation in exon 8 and 10. Only one tumor had mutation in exon 11, and sequence analysis veri!ied new mutation -deletion of 20 bp (from 133-153 bp).. PCR-SSCP examination of 60 samples did not indicate other different types of SSCP variants. The malignant progression is a consequence more than one genetic change, and inactivation of DPC4 had a role 1n a multistep process of colon carcinoma progression.

DPC4; carcinoma; mutations

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

S50-x.

2002.

objavljeno

Podaci o matičnoj publikaciji

Eur J Cancer

Moranr, R.

Sankt Gallen: Pergamon

Podaci o skupu

2nd International conference and 7th annual meeting of the international society of cancer chemoprevention ISCaC

poster

14.02.2002-16.02.2002

St. Gallen, Švicarska

Povezanost rada

Javno zdravstvo i zdravstvena zaštita, Farmacija